16 April 2014
Details
SCHENECTADY, NY
SI Group, Inc. announced today that
it has signed a deal to
acquire the Antioxidants, Ibuprofen, and
related businesses and assets
from Albemarle Corporation (NYSE:ALB).
The transaction includes
manufacturing sites in Orangeburg, South Carolina,
United States and Jinshan, China.
This deal expands
SI Group’s antioxidants business and
will position the company as
one of the top three global suppliers of Ibuprofen.
said Frank Bozich,
SI Group President & CEO.
“It’s the largest deal in SI Group’s history,”
“This acquisition is a natural fit to
our expansion strategy, transforming SI Group
into a solutions leader in the global antioxidant
and pharmaceutical active ingredients markets.”
The acquisition will include
* Albemarle’s antioxidant product lines, as well as
* the FDA-regulated Ibuprofen and
Propofol businesses.
In addition,
applications and technical support capabilities
in Shanghai and Baton Rouge, Louisiana, United States
will be included in the transaction.
said Stephen Haller,
Senior Vice President of Strategy and
New Business Development.
in SI Group’s strategy of
* expanding into complementary,
faster growing markets
* while at the same time continuously improving
our core business through business excellence,”
Subject to the required regulatory approvals,
this acquisition is expected to be completed later this year.
WWW.CHEMWINFO.COM BY KHUN PHICHAI
